Tag: Perfuze
Perfuze announces US FDA 510(k) clearances for novel aspiration and access...
Perfuze has announced US Food and Drug Administration (FDA) clearances for the Millipede 070 aspiration catheter and the second-generation of its Millipede 088 access...
Perfuze enrols first stroke patient in MARRS pivotal trial of Millipede...
Perfuze has announced commencement of enrolment in its pivotal MARRS study—a multicentre trial set to evaluate the performance of aspiration thrombectomy with the company’s...
Perfuze announces US FDA clearance and first US clinical use of...
Perfuze has secured its first product clearance from the US Food and Drug Administration (FDA) for the company’s Millipede 088 access catheter. The first...
Perfuze raises €22.5m in Series A funding for novel acute ischaemic...
Perfuze announced today that it has closed a €22.5 million Series A investment round—the proceeds from which will be used to drive the next...
